|
6 Companies |
|
10 Products |
|
10 Products |
|
12 Mechanisms of Action |
|
0 Trials |
|
160 News |
|
| «1234» |
- New P1 trial: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects (clinicaltrials.gov) - Apr 2, 2014
P1, N=80, Recruiting, Sponsor: Molecular NeuroImaging
- ||| Biomarker, Trial completion: Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION (clinicaltrials.gov) - Mar 5, 2014
P=N/A, N=204, Completed, Sponsor: Neuronetrix, Inc.
Recruiting --> Completed
- | Trial completion: Role of the Right Brain in Recovery of Language Function in Chronic Stroke (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=40, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Direct Current Brain Polarization in Frontotemporal Dementia (clinicaltrials.gov) - Feb 22, 2014
P1, N=6, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: AERs in Aphasia: Severity and Improvement (clinicaltrials.gov) - Feb 19, 2014
P2, N=20, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed No longer recruiting --> Completed
- | New P1/2 trial: An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=105, Recruiting, Sponsor: Kessler Foundation
- Enrollment open, Metastases: GIRDH: Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players (clinicaltrials.gov) - Jan 29, 2014
P=N/A, N=120, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
No longer recruiting --> Completed Not yet recruiting --> Recruiting
- Trial initiation date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Jan 23, 2014
P=N/A, N=12, Not yet recruiting, Sponsor: Duke University
Not yet recruiting --> Recruiting Initiation date: Aug 2013 --> Jan 2014
- Trial initiation date: Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia (clinicaltrials.gov) - Jan 8, 2014
P2, N=112, Recruiting, Sponsor: Georgetown University
Initiation date: Aug 2013 --> Jan 2014 Initiation date: Sep 2012 --> Dec 2012
- Enrollment closed: Effect of Verb Network Strengthening Treatment (VNeST) on Lexical Retrieval in Aphasia (clinicaltrials.gov) - Jan 1, 2014
P2, N=15, Active, not recruiting, Sponsor: Department of Veterans Affairs
Initiation date: Sep 2012 --> Dec 2012 Recruiting --> Active, not recruiting
- Trial termination: Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia (clinicaltrials.gov) - Dec 17, 2013
P3, N=30, Terminated, Sponsor: University of Magdeburg
Recruiting --> Active, not recruiting Recruiting --> Terminated; recruitment efforts did not result in a sufficient number of patients
- Clinical: Web-Based CBT Protocol for Treatment of Selective Mutism (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=38, Completed, Sponsor: National Healthcare Group, Singapore
- Trial completion: FTDOXY10EF: Safety Study of Intranasal Oxytocin in Frontotemporal Dementia (clinicaltrials.gov) - Oct 31, 2013
P1, N=23, Completed, Sponsor: Lawson Health Research Institute
Recruiting --> Terminated; recruitment efforts did not result in a sufficient number of patients Recruiting --> Completed
- ||||| LMTX (hydromethylthionine) / TauRx
Trial initiation date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Oct 8, 2013
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Recruiting --> Completed Initiation date: Feb 2013 --> Aug 2013
- | Trial completion, Enrollment change: Dopaminergic Enhancement of Learning and Memory in Aphasia (clinicaltrials.gov) - Oct 3, 2013
P4, N=12, Completed, Sponsor: University Hospital Muenster
Initiation date: Feb 2013 --> Aug 2013 N=10 --> 12 | Recruiting --> Completed
- Trial completion: Dopaminergic Enhancement of Learning and Memory in Aphasia (clinicaltrials.gov) - Oct 3, 2013
P4, N=12, Completed, Sponsor: University Hospital Muenster
N=10 --> 12 | Recruiting --> Completed Recruiting --> Completed
- Enrollment open: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia (clinicaltrials.gov) - Oct 3, 2013
P2, N=72, Recruiting, Sponsor: Lawson Health Research Institute
Recruiting --> Completed Not yet recruiting --> Recruiting
- | New P2 trial: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia (clinicaltrials.gov) - Sep 5, 2013
P2, N=72, Recruiting, Sponsor: Lawson Health Research Institute
- Enrollment change: FCET2EC: Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions (clinicaltrials.gov) - Aug 13, 2013
P=N/A, N=126, Recruiting, Sponsor: University Hospital Muenster
Not yet recruiting --> Recruiting N=168 --> 126
- | New P2 trial: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. (clinicaltrials.gov) - Jun 27, 2013
P2, N=28, Completed, Sponsor: Avid Radiopharmaceuticals
- Enrollment closed: Transcranial Direct Current Stimulation and Aphasia Language Therapy (clinicaltrials.gov) - Jun 21, 2013
P1, N=12, Active, not recruiting, Sponsor: Rehabilitation Institute of Chicago
N=168 --> 126 Recruiting --> Active, not recruiting
- Enrollment change: Integrated Behavioral Therapy for Treating Children With Selective Mutism (clinicaltrials.gov) - May 29, 2013
P=N/A, N=21, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Active, not recruiting N=32 --> 21
- Trial completion: Integrated Behavioral Therapy for Treating Children With Selective Mutism (clinicaltrials.gov) - May 29, 2013
P=N/A, N=21, Completed, Sponsor: University of California, Los Angeles
N=32 --> 21 Active, not recruiting --> Completed
- Enrollment closed: Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia (clinicaltrials.gov) - Apr 17, 2013
P2, N=28, Active, not recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis (clinicaltrials.gov) - Apr 14, 2013
P=N/A, N=10, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||| LMTX (hydromethylthionine) / TauRx
Enrollment open: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Mar 26, 2013
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=30, Recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment change: MJFFSpeech: Improve Speech Using an In-the-ear Device in Parkinson's Disease (clinicaltrials.gov) - Jan 16, 2013
P1, N=40, Completed, Sponsor: Rush University Medical Center
Not yet recruiting --> Recruiting N=100 --> 40
- Trial completion: MJFFSpeech: Improve Speech Using an In-the-ear Device in Parkinson's Disease (clinicaltrials.gov) - Jan 16, 2013
P1, N=40, Completed, Sponsor: Rush University Medical Center
N=100 --> 40 Active, not recruiting --> Completed
- Enrollment closed: Transcranial Magnetic Stimulation to Improve Speech in Aphasia (clinicaltrials.gov) - Jan 8, 2013
P2, N=90, Active, not recruiting, Sponsor: Boston University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- miglustat / Generic mfg.
New P3 trial: Application of Miglustat in Patients With Niemann-Pick Type C (clinicaltrials.gov) - Jan 2, 2013
P3, N=5, Completed, Sponsor: National Taiwan University Hospital
- Trial completion: Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes (clinicaltrials.gov) - Dec 12, 2012
P1/2, N=18, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Clinical: Living With Frontotemporal Dementia (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=40, Recruiting, Sponsor: National Human Genome Research Institute (NHGRI)
- Enrollment open: FCET2EC: Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions (clinicaltrials.gov) - Nov 11, 2012
P=N/A, N=126, Recruiting, Sponsor: University Hospital Muenster
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | New P2 trial: Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia (clinicaltrials.gov) - Oct 16, 2012
P2, N=112, Recruiting, Sponsor: Georgetown University
- Enrollment change: BIOMAGE: Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease (clinicaltrials.gov) - Oct 7, 2012
P=N/A, N=60, Completed, Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting --> Recruiting N=100 --> 60
- Trial completion: BIOMAGE: Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease (clinicaltrials.gov) - Oct 7, 2012
P=N/A, N=60, Completed, Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
N=100 --> 60 Recruiting --> Completed
- Clinical: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Sep 11, 2012
P=N/A, N=12, Not yet recruiting, Sponsor: Duke University
- asenapine / Generic mfg.
New P4 trial: A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering (clinicaltrials.gov) - Sep 11, 2012
P4, N=32, Not yet recruiting, Sponsor: University of California, Irvine
- |||| Trial completion: EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study (clinicaltrials.gov) - Aug 19, 2012
P2, N=120, Completed, Sponsor: Endo Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Performance of AclarusDx (clinicaltrials.gov) - Jul 3, 2012
P=N/A, N=160, Completed, Sponsor: Exonhit
Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| LMTX (hydromethylthionine) / TauRx
New P3 trial: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Jun 20, 2012
P3, N=180, Recruiting, Sponsor: TauRx Therapeutics Ltd
- Clinical: MCIAT: Study of Modified Constraint-Induced Aphasia Therapy Schedule to Treat Patients Following Sub-acute Stroke (clinicaltrials.gov) - Jun 14, 2012
P=N/A, N=100, Completed, Sponsor: NRZ Magdeburg Median Kliniken GmbH & Co
- carbidopa/levodopa / Generic mfg.
Trial completion, Combination therapy: Augmenting Language Therapy for Aphasia: Levodopa (clinicaltrials.gov) - Jun 12, 2012
P2/3, N=36, Completed, Sponsor: Rehabilitation Institute of Chicago
Recruiting --> Completed Recruiting --> Completed
- || memantine / Generic mfg.
Trial completion, FDG PET: Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia (clinicaltrials.gov) - May 31, 2012
P3, N=17, Completed, Sponsor: Tiffany Chow, MD
Recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - May 9, 2012
P1, N=8, Recruiting, Sponsor: Rehabilitation Institute of Chicago
- Trial completion: Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS) (clinicaltrials.gov) - May 7, 2012
P2, N=0, Completed, Sponsor: Pharmacology Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Treating Intention In Aphasia: Neuroplastic Substrates (clinicaltrials.gov) - Apr 26, 2012
P1/2, N=14, Completed, Sponsor: University of Florida
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Trial completion: A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering (clinicaltrials.gov) - Jan 11, 2012
P2/3, N=321, Completed, Sponsor: Endo Pharmaceuticals
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis (clinicaltrials.gov) - Dec 19, 2011
P=N/A, N=10, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed N=24 --> 10